A Phase 2 Trial to Investigate Efficacy and Safety of Vipoglanstat in Women With Endometriosis

Inclusion Criteria:

• Premenopausal females 18 to < 45 years of age at the time of Visit 1.

• Endometriosis diagnosis confirmed and documented within the last 10 years prior toVisit 1 or during Visit based on:

• Surgical (via direct visualization or biopsy verified) or

• Imaging (ie, endometriotic lesion(s) detected by transvaginal sonography ormagnetic resonance imaging [MRI].

• History of NMPP significantly affecting daily life confirmed at Visit 1.

• The participant reports moderate, severe, or very severe pain during non-menstrualdays in the month prior to Visit 2, based on patient global assessment NMPP.

Exclusion Criteria:

• Chronic pelvic pain that is not judged to be primarily related to endometriosis (eg,chronic pelvic infection, interstitial cystitis, nerve entrapments or neuropathies,non-endometriosis-related pelvic adhesive disease, persistent symptomatic ovariancyst [eg, dermoid], posttubal ligation, symptomatic hydrosalpinx, and vaginismus).

• Has had more than 2 surgical procedures for endometriosis.